Cancer Research Technology Limited (2016) Pyrrolcarboxamide derivatives for the inhbition of ERK5. PCT/GB2015/052707.

Full text not available from this repository.

Abstract

The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5, in particular cancers.

Item Type:	Patent
Schools and Departments:	School of Life Sciences > Chemistry
Depositing User:	Tristan Reuillon
Date Deposited:	31 Oct 2016 07:54
Last Modified:	31 Oct 2016 07:54
URI:	http://sro.sussex.ac.uk/id/eprint/60204

📧 Request an update